Put Options

8 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2023

Nov 15, 2023

BUY
$50.28 - $64.61 $211,176 - $271,362
4,200 New
4,200 $243,000
Q2 2022

Aug 15, 2022

SELL
$23.09 - $33.46 $184,720 - $267,680
-8,000 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$26.91 - $47.15 $45,747 - $80,155
1,700 Added 26.98%
8,000 $231,000
Q4 2021

Feb 14, 2022

BUY
$32.97 - $56.85 $207,711 - $358,155
6,300 New
6,300 $295,000
Q4 2018

Feb 14, 2019

SELL
$41.17 - $56.44 $259,371 - $355,572
-6,300 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$52.95 - $71.34 $52,950 - $71,340
-1,000 Reduced 13.7%
6,300 $356,000
Q1 2018

May 15, 2018

BUY
$56.98 - $72.41 $91,168 - $115,856
1,600 Added 28.07%
7,300 $425,000
Q4 2017

Feb 14, 2018

BUY
$53.3 - $74.56 $303,810 - $424,992
5,700
5,700 $367,000

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $986M
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.